Finn
WLYB Publishing · Research publishing · Education content · AI licensing · Thesis updated September 13, 2026

Research is carrying a shrinking Learning business

01 Running thesis

Research has the lead

Wiley has settled into a two-part story. Research is growing solidly, while Learning continues to shrink. In the first quarter of fiscal 2027, Research publishing revenue grew 12%, or 6% organically, while Learning fell 10% organically due to retail channel softness.

The bull case is strengthening around Research and new data analytics segments. AI licensing revenue proved it can repeat, with $14 million realized in the first quarter and another $14 million contracted. Clinical outcome assessments, a fast-growing unit, saw revenue triple in the same period. The Emerald Publishing acquisition is also contributing ahead of schedule.

The bear case remains focused on the terminal decline of the Learning segment. The organic decline highlights ongoing structural challenges and channel headwinds. If AI revenue stalls or fails to become mostly recurring, Research growth could slow down, leaving the company heavily dependent on Emerald cost synergies.

Over the next year, investors will watch whether Wiley can deliver the contracted AI revenue, scale its clinical outcome assessments, and stabilize the retail channel inventory issues in the Learning segment.

Sep 2026▲Q1 FY27 results confirmed strong execution in Research with 12% growth, while Learning declined 10% organically. AI licensing proved repeatable, and clinical outcome assessments emerged as a fast-growing unit.
Jun 2026▲FY26 results moved the thesis back to a split story. Research grew 4% in constant currency, Learning fell 7%, and the Emerald Publishing deal added more weight to the Research strategy.
Mar 2026→Q3 FY26 blurred the picture. Research slowed to 1% constant currency growth, while Learning's decline moderated to 2%, making the company look more stagnant than sharply split.
Dec 2025▼Q2 FY26 showed a sharper split. Research grew 5% in constant currency, but Learning fell 11% because of market softness and inventory pressure.
Sep 2025▼Q1 FY26 weakened the story. Research benefited from AI revenue, but Learning fell 8% in constant currency, showing that AI timing can hide weak core demand.
Jun 2025▲FY25 looked better because Learning grew 2%, helped by AI-related content licensing. The same filing also made AI risk more visible.
Mar 2025▼Q3 FY25 hurt the turnaround case. Learning fell 6% in constant currency, while Research growth excluding GenAI was not strong enough to offset the pressure.
02 Business model

Digital content, licensed many ways

Wiley sells trusted content. In Research, it licenses journals and platforms to universities, companies, and government customers. It also earns money when authors or funders pay to publish open access research, meaning readers can access the article without a paywall.

The company is mostly digital. Wiley reported 85% of fiscal 2026 revenue came from digital products and services, and 48% of total revenue was recurring. Recurring revenue provides stability compared to one-time book sales.

Learning sells digital and print books, courseware, and professional assessment services. This side is under pressure from weak print demand, retail softness, and shifting education buying patterns.

AI and data analytics act as an emerging growth engine. Wiley licenses its proprietary content library to train AI models. This revenue stream is formalizing into one-time model training and recurring subscription knowledge feeds.

03 Product portfolio

What Wiley sells

Cash cow

Research journals and platforms

This is the core Research business. It sells peer-reviewed scientific, technical, and medical content to institutions and other professional customers.

Growth engine

Open access publishing

Authors or their funders pay so research can be read without a paywall. This area provides solid organic publishing growth.

Option

AI content licensing

Wiley licenses its content for training AI models. This segment generated $14 million in the first quarter of fiscal 2027 and is shifting toward recurring subscriptions.

Growth engine

Clinical outcome assessments

These are peer-reviewed instruments used in clinical trials. The portfolio grew from $6 million in fiscal 2025 to $11 million last year, and revenue tripled in the latest quarter.

Growth engine

Emerald Publishing

Wiley bought Emerald for about $462 million. The deal adds scale in Research and bolsters the content advantage in AI applications for the company.

Steady

Academic and professional books

This is part of the Learning segment, which is facing persistent headwinds in trade publishing due to retail channel inventory normalization.

04 Business segments

Two segments moving apart

Research67%modest
Learning33%declining

Segment mix is from fiscal 2026, ended April 30, 2026. Research was 67% of consolidated revenue and Learning was 33%, before the Emerald Publishing acquisition increased Research scale.

05 Risk factors

What could go wrong

AI licensing may not transition well

High impact · Medium odds

Wiley realized $14 million of AI revenue in the latest quarter, but only $3.5 million was recurring. If the AI licensing pipeline stalls or fails to shift to a recurring model, Research growth could decelerate.

We watchThe mix of recurring versus one-time AI revenue and management updates on new subscription deals.

Learning keeps shrinking

High impact · High odds

Learning revenue fell 10% organically in the first quarter of fiscal 2027. Structural challenges and retail channel headwinds persist. If that decline becomes permanent, Research must do more work just to keep total revenue flat.

We watchLearning organic revenue growth and management comments on retail channel inventory.

Emerald integration execution

Medium impact · Medium odds

Wiley bought Emerald Publishing to extend its Research scale. While early integration is ahead of schedule, the company still needs to realize full revenue and cost synergies to justify the price.

We watchEmerald revenue contribution, margin profile, and synergy updates in upcoming quarters.

AI can also disrupt Wiley

Medium impact · Medium odds

Wiley can sell content to AI firms, but AI can also create new competition, legal risk, compliance costs, and possible cannibalization. The same technology that creates licensing upside could weaken demand for some content products.

We watchNew AI copyright rulings, customer use of AI substitutes, and company legal or compliance cost disclosures.
06 Quick answers

In one breath

What does John Wiley & Sons do?

Wiley publishes research, academic, professional, and learning content. Its biggest business is Research, which serves universities, companies, governments, and researchers.

Why does AI matter for Wiley?

AI companies can license Wiley content to train large language models. The company is working to shift this revenue from one-time deals into recurring subscriptions.

Is Wiley growing?

Parts of it are growing, but the whole picture is mixed. Research publishing is growing solidly, while the Learning segment is facing structural declines.

What should investors watch next?

Watch whether Wiley can sign more recurring AI subscription deals, scale its clinical outcome assessments, and stabilize the decline in the Learning segment.

07 Research standards

Sources and research notes

This page combines Finn's company research with public filings and other cited materials. The thesis is reviewed when material company information changes; Finn Scores use the latest available scoring data.

Thesis reviewed
September 13, 2026
Score data
September 27, 2026
Reviewed by
Shivam Bharuka
  1. John Wiley & Sons Q1 FY2027 Earnings Call
  2. John Wiley & Sons FY2026 Form 10-K
08 Explore the industry

Comparable Publishing companies

Companies near John Wiley & Sons, Inc. in Finn's Publishing industry ranking.

Get started with Finn today